Sage Journals: Discover world-class research

Open access

Research article

First published 2020-7

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

CE Leurs, HAM Twaalfhoven, BI Lissenberg-Witte [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2021

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid

Franz F Konen, Philipp Schwenkenbecher, Ulrich Wurster [...]

Journal of Central Nervous System Disease

Retricted access

Research article

First published 2022-8

The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study

Gaetano Bernardi, Tiziana Biagioli, Paola Malpassi [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2016-4

Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study

Stefan Presslauer, Dejan Milosavljevic, Wolfgang Huebl [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-10

The kappa free light chains index is an accurate diagnostic biomarker for paediatric multiple sclerosis

Aurélie Sarthou, Pascale Chrétien, Laetitia Giorgi [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2026-2

Optimizing kappa free light chain index thresholds for multiple sclerosis (MS) diagnosis in low-MS prevalence regions: Insights from an Asian cohort

Su-Hyun Kim, You-Ri Kang, Jieun Chung [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2025-11

Performance of the Binding Site cerebrospinal fluid kappa free light chains assay

Simon Alfred Handley, Suzanne Barnes, Nicole Jenkins [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Retricted access

Research article

First published 2017-10

Prognostic value of free light chains lambda and kappa in early multiple sclerosis

Margarete M Voortman, Tatjana Stojakovic, Lukas Pirpamer [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

Klaus Schmierer, Heinz Wiendl, Frederik Barkhof [...]

Therapeutic Advances in Neurological Disorders

Search results